Volume 10, Number 5—May 2004
Research
Enzyme-Linked Immunosorbent Assay and Serologic Responses to Pneumocystis jiroveci
Table 2
Adjusted odds ratios (95% CI) measuring the associations between Western blot reactivity and ELISA values (25–75 percentile increase) among 189 study participantsa,b
ELISA | Blood donor, n = 95 (95% CI) | PCP+, n = 33 (95% CI) | PCP–, n = 61 (95% CI) | HIV, n = 94 (95% CI) |
---|---|---|---|---|
1 |
1.1 (0.9 to 1.4) |
5.1 (2.2 to 11.8) |
1.4 (0.8 to 2.6) |
2.7 (1.2 to 5.8) |
2 |
1.1 (0.9 to 1.4) |
20.4 (6.4 to 65.1) |
3.6 (2.0 to 6.6) |
8.6 (4.4 to 16.9) |
3 | 1.0 (0.9 to 1.1) | 11.6 (3.6 to 37.9) | 7.4 (3.6 to 15.1) | 9.3 (4.7 to 18.5) |
aCI, confidence interval; ELISA, enzyme-linked immunosorbent assay; PCP, Pneumocystis pneumonia.
bOdds ratios were obtained by using logistic regression. Positive associations were found between Western blot reactivity and increasing ELISA. Based on 95% confidence intervals, the odds of Western blot reactivity were significantly related (p < 0.05) to increasing ELISA 1, 2, and 3 among PCP+ patients and HIV patients across all antigens. For PCP– patients this result was true for ELISA 2 and 3 only. No significant results were found for the blood donor group.